IL10 and neoplasm: This was also consistent with earlier reports showing that alternatively activated M2-like TAMs, which are known to harbor induced IL10 rather than induced IL12, promote tumor progression, whereas the IL12-expressing M1-type TAMs are tumoricidal [7,80].